Moreover, high endogenous insulin concentrations observed in patients with type 2 diabetes mellitus are associated with reduced hepatic synthesis of IGFBP-1 (the main IGF-1 binding globulin), leading to increased bio-availability of IGF-1 and possible enhancement of its known mitogenic effects [8,24]. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.